News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Suzanne B. Merrill, MD, FACS

Articles by Suzanne B. Merrill, MD, FACS

Experts discuss how checkpoint inhibitors, cystectomy, and other treatment modalities fit into the current landscape for non–muscle-invasive bladder cancer.

Optimizing Therapeutic Strategies Across the NMIBC Paradigm

ByManojkumar Bupathi, MD, MS,Benjamin Garmezy, MD,Suzanne B. Merrill, MD, FACS,Mark D. Tyson, II, MD, MPH

May 14th 2026

Latest Updated Articles

Trending on CancerNetwork

FDA OKs Oral Decitabine/Cedazuridine Plus Venetoclax in Newly Diagnosed AML

FDA Approves Sonrotoclax in Relapsed/Refractory Mantle Cell Lymphoma

How Might CAR T Cells and Bispecifics Evolve in Multiple Myeloma Therapy?

Novel Adenoid Cystic Carcinoma Drug Earns FDA Breakthrough Therapy Status

Mitomycin Exhibits Sustained 36-Month Responses in LG-IR-NMIBC